InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Monday, 12/12/2016 3:25:20 PM

Monday, December 12, 2016 3:25:20 PM

Post# of 232961
While awaiting a reply, I found this in the interim:

http://online.liebertpub.com/doi/abs/10.1089/vim.2013.0067#/doi/abs/10.1089/vim.2013.0067

It's possible that HBsAG creates antibodies that compete with PRO 140 for the same CCR5 receptor sites. With an estimated 300M-400M people having this antigen, coupled with rates of STIs being higher in HIV patients, maybe management found their answer.

All speculation on my part of course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News